Cite
Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes.
MLA
Montalban-Bravo, Guillermo, et al. “Transcriptomic Analysis Implicates Necroptosis in Disease Progression and Prognosis in Myelodysplastic Syndromes.” Leukemia, vol. 34, no. 3, Mar. 2020, pp. 872–81. EBSCOhost, https://doi.org/10.1038/s41375-019-0623-5.
APA
Montalban-Bravo, G., Class, C. A., Ganan-Gomez, I., Kanagal-Shamanna, R., Sasaki, K., Richard-Carpentier, G., Naqvi, K., Wei, Y., Yang, H., Soltysiak, K. A., Chien, K., Bueso-Ramos, C., Do, K.-A., Kantarjian, H., & Garcia-Manero, G. (2020). Transcriptomic analysis implicates necroptosis in disease progression and prognosis in myelodysplastic syndromes. Leukemia, 34(3), 872–881. https://doi.org/10.1038/s41375-019-0623-5
Chicago
Montalban-Bravo, Guillermo, Caleb A Class, Irene Ganan-Gomez, Rashmi Kanagal-Shamanna, Koji Sasaki, Guillaume Richard-Carpentier, Kiran Naqvi, et al. 2020. “Transcriptomic Analysis Implicates Necroptosis in Disease Progression and Prognosis in Myelodysplastic Syndromes.” Leukemia 34 (3): 872–81. doi:10.1038/s41375-019-0623-5.